Profound Bio
AcquiredRedmond, United States · $237.0M raised
- Headquarters
- Redmond, Washington
- Business Model
- B2B
- Website
- profoundbio.com
- Total Funding
- $237.0M
- Last Round
- $112.0M Series BFeb 2024
- Rounds
- 3
About
Clinical-stage biotech developing antibody-drug conjugates; acquired by Genmab in 2024.
Summary
Profound Bio is a Biotech company based in Redmond, United States. It has raised $237.0M in total across 3 rounds, most recently a $112.0M Series B round in Feb 2024. Investors include Lilly Asia Ventures, Genmab and Ally Bridge Group.
Tech & App Stack
11 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.